Literature DB >> 8822970

Cyclosporine-associated neurotoxicity. The need for a better guide for immunosuppressive therapy.

L W Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8822970     DOI： 10.1161/01.cir.94.6.1209

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

Authors:  X Jiang; T T Nguyen; W Tian; Y K Sung; K Yuan; J Qian; J Rajadas; J-M Sallenave; N P Nickel; V de Jesus Perez; M Rabinovitch; M R Nicolls
Journal:  Am J Transplant       Date:  2015-02-27       Impact factor: 8.086

2.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

3.  Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians-comment.

Authors:  Jayendra Shukla; Anuraag Jena; Vishal Sharma
Journal:  Intern Emerg Med       Date:  2021-04-19       Impact factor: 3.397

4.  A 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Maria Tavakoli Ardakani; Ali Tafazoli; Mahshid Mehdizadeh; Abbas Hajifathali; Simin Dadashzadeh
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Diffusion MRI Findings in Encephalopathy Induced by Immunosuppressive Therapy after Liver Transplantation.

Authors:  Emanuele Tinelli; Nicoletta Locuratolo; Alberto Pierallini; Massimo Rossi; Francesco Fattapposta
Journal:  Case Rep Med       Date:  2020-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.